Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

IMMX vs NVCT: stock comparison and AI forecast

Immix Biopharma, Inc. (IMMX) and Nuvectis Pharma, Inc. (NVCT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

IMMX Immix Biopharma, Inc.

Price
$7.26 -23.4% · 6M
Market Cap
$602M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

NVCT Nuvectis Pharma, Inc.

Market Cap
$625M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

IMMX · NVCT

Key facts

  • IMMX and NVCT have similar market capitalizations ($602M and $625M).
  • NVCT carries 1.46 times debt per unit of equity, against 0.04 times for IMMX.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricIMMXNVCT
Market Cap$602M$625M
P/B Ratio2.63x68.81x
EPS$-0.85$-1.32
Book Value/Share$2.76$0.28
FCF/Share$-0.47–

Profitability & Margins

MetricIMMXNVCT
ROE-18.8%-306.6%
ROA-18.0%-124.5%
ROIC-18.2%–
Tax Rate-0.1%–

Financial Health

MetricIMMXNVCT
Current Ratio25.13x1.68x
D/E Ratio0.04x1.46x
Financial Leverage1.04x2.46x
Interest Coverage-3427.9x–
Working Capital$224M$9M

Cash Flow

MetricIMMXNVCT
Operating Cash Flow-$38M-$20M
Free Cash Flow-$39M–
Capital Spending-$590K–

Income Statement

MetricIMMXNVCT
Operating Income-$42M-$29M
Net Income-$43M-$28M
R&D Expense$22M$20M

Dividend & Shareholder Information

MetricIMMXNVCT
Shares Outstanding83M33M
FAQ

IMMX vs NVCT: stock comparison and AI forecast

Which is bigger, IMMX or NVCT?

IMMX and NVCT have similar market capitalizations ($602M and $625M).

Which one does Intratio's AI model rank higher, IMMX or NVCT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.